Drug class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor; Cytochrome P450 3A Inhibitor; Protease Inhibitor; Antiviral
Mechanism of action
Nucleoside Reverse Transcriptase Inhibitors [MoA]
General use cases
- Hepatitis B, Chronic
- Acquired Immunodeficiency Syndrome
- HIV-1 infection in adults and adolescent patients weighing at least 35 kg
- chronic hepatitis B virus (HBV) infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease [see Clinical Studies (14) ]
- chronic hepatitis B virus infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
